| Secondary |
| Product Used For Unknown Indication |
29.6% |
| Drug Use For Unknown Indication |
28.4% |
| Agitation |
9.0% |
| Depression |
3.5% |
| Hiv Infection |
3.3% |
| Hypertension |
3.1% |
| Abnormal Behaviour |
2.8% |
| Dementia Alzheimer's Type |
2.4% |
| Transplant |
2.1% |
| Psychotic Disorder |
1.9% |
| Diabetes Mellitus |
1.7% |
| Intentional Overdose |
1.7% |
| Prophylaxis |
1.7% |
| Vascular Dementia |
1.7% |
| Dementia |
1.4% |
| Ill-defined Disorder |
1.4% |
| Atrial Fibrillation |
1.2% |
| Hiv Test Positive |
1.2% |
| Insomnia |
1.2% |
| Aggression |
0.9% |
|
| Somnolence |
10.0% |
| Vascular Purpura |
10.0% |
| Abnormal Behaviour |
7.1% |
| Confusional State |
7.1% |
| Renal Failure |
7.1% |
| Aggression |
5.7% |
| Fall |
5.7% |
| Hypothermia |
5.7% |
| Vomiting |
5.7% |
| Hyponatraemia |
4.3% |
| Psychomotor Skills Impaired |
4.3% |
| Respiratory Distress |
4.3% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Bradycardia |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Lung Disorder |
2.9% |
| Monocytosis |
2.9% |
| Mydriasis |
2.9% |
| Neuroleptic Malignant Syndrome |
2.9% |
| Neutropenia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Drug Use For Unknown Indication |
18.1% |
| Agitation |
6.5% |
| Non-small Cell Lung Cancer |
5.1% |
| Depression |
4.9% |
| Hypertension |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.4% |
| Atrial Fibrillation |
4.2% |
| Psychotic Disorder |
3.7% |
| Anxiety |
2.8% |
| Dementia |
2.8% |
| Prophylaxis |
2.7% |
| Rash |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Premedication |
2.6% |
| Pain |
2.5% |
| Arrhythmia |
2.2% |
| Epilepsy |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Abnormal Behaviour |
2.0% |
|
| Thrombocytopenia |
16.7% |
| Renal Failure |
14.2% |
| Vomiting |
9.2% |
| Renal Failure Acute |
8.3% |
| Somnolence |
5.0% |
| Multi-organ Failure |
4.2% |
| Pancytopenia |
4.2% |
| Sepsis |
4.2% |
| Aspartate Aminotransferase Increased |
3.3% |
| Drug Interaction |
3.3% |
| Hypothermia |
3.3% |
| Tachypnoea |
3.3% |
| Urinary Retention |
3.3% |
| Affective Disorder |
2.5% |
| Cytolytic Hepatitis |
2.5% |
| Face Oedema |
2.5% |
| General Physical Health Deterioration |
2.5% |
| Hypotension |
2.5% |
| Overdose |
2.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
44.1% |
| Depression |
17.6% |
| Pain |
8.8% |
| Insomnia |
5.9% |
| Major Depression |
5.9% |
| Agitation |
2.9% |
| Alcohol Detoxification |
2.9% |
| Alcohol Withdrawal Syndrome |
2.9% |
| Convulsion |
2.9% |
| Diabetes Mellitus |
2.9% |
| Urinary Incontinence |
2.9% |
|
| Drug Interaction |
33.3% |
| Fall |
11.1% |
| Hypothermia |
11.1% |
| International Normalised Ratio Increased |
11.1% |
| Pneumonia Aspiration |
11.1% |
| Road Traffic Accident |
11.1% |
| Urinary Retention |
11.1% |
|
